Sky Century Investment, Inc. (SKYI) Stock
Sky Century Investment, Inc. is engaged in the sale of cannabidiol (CBD) items crafted with pharmaceutical-grade components.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Sky Century Investment, Inc.
Sky Century Investment, Inc. is engaged in the sale of cannabidiol (CBD) items crafted with pharmaceutical-grade components. In addition to its product line, the firm offers an array of digital services such as marketing strategy, meticulous planning, search engine optimization (SEO), detailed analytics, and insightful reporting. Moreover, it provides bespoke content and website development, alongside mail marketing campaigns, specifically aimed at companies involved in the creation of CBD goods. Established in 2012, Sky Century's headquarters are situated in Las Vegas, Nevada.
Sky Century Investment, Inc. is headquartered in US.
Sky Century Investment, Inc. (SKYI) stock trades at $0.18 with a market capitalization of $402386. The stock is valued at a negative price-to-earnings (P/E) ratio of -6.55, reflecting a net loss over the last twelve months, a negative price-to-book of -3.11, reflecting negative shareholders' equity, price-to-sales of 3.19. Over the past 52 weeks the stock has ranged between $0.01 and $2.10, and currently trades 91.4% below its 52-week high.
On profitability, Sky Century Investment, Inc. generates a return on equity (ROE) of 22.00%, above the typical market range of roughly 12-15%, return on capital employed of 27.43%, an operating margin of -49.48%, a net profit margin of -49.48%.
Official website: skygcbd.com
Related Healthcare Stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.